Yet despite the lack of large-scale human research, pharmaceutical-grade BPC-157 is available to indicated users, and many people do opt to take advantage of its availability
Targeted therapy and ototoxicity Newer therapies aimed at specific cancer types, such as tyrosine kinase inhibitors (TKIs), have been associated with vestibular dysfunction, though their precise ototoxic mechanisms remain under investigation
One notable example is research by Khorram et al
If your label does not clearly state the concentration, calculate it yourself
Since ginkgetin was isolated as a standalone compound in 1996, research reports on its biological activity have continuously emerged, including anti-inflammatory [20, 21], anti-bacterial [22, 23], anti-fungal [24, 25], anti-virus [26], anti-atherosclerosis [27, 28], anti-adipogenesis [29], anti-oxidant [30, 31], anti-senescence [32, 33], anti-fibrotic [34, 35] and neuroprotective [36, 37]